Category stocks

Exagen Q1 Earnings Call Highlights

Key Points - Exagen posted record Q1 revenue of $17.3 million, up 12% year over year, and reaffirmed its full-year 2026 revenue guidance of $70 million to $73 million. Gross margin held at 59% while adjusted EBITDA loss improved to $2.2 million. - Growth was driven by stro